Please login to the form below

Not currently logged in

bluebird bio lodges counterclaim against Spark Therapeutics

Spark previously accused bluebird of misusing trademarks relating to the word ‘spark’ in marketing/educational materials

bluebird bio has launched a counterclaim against Spark Therapeutics after the latter initiated a dispute a few months ago, according to Boston Business Journal.

Earlier this year, Spark filed a lawsuit against bluebird alleging that the company misused trademarks relating to the word ‘spark’ in marketing/educational materials.

Specifically, the complaint accuses bluebird bio of infringing on and diluting Spark Therapeutics’ trademark, relating to bluebird bio’s educational and informational campaign about sickle cell disease ‘Be the Spark’ which was shared on social media sites and other locations.

In response, bluebird bio’s counterclaim says Spark’s lawsuit is a ‘misguided exercise’, with the Philadelphia Business Journal reporting that the counterclaim argues that the word ‘spark’ is free to use under the doctrine of fair use.

In addition, bluebird bio has argued that it did not wilfully infringe on Spark Therapeutics, using the word ‘spark’ solely to describe its ‘goods and services’.

bluebird bio is developing its gene therapy LentiGlobin for sickle cell disease, which currently has an orphan drug designation as well as fast track and rare paediatric disease designations from the US Food and Drug Administration (FDA).

Spark Therapeutics was acquired by Roche for $4.3bn in February 2019, enabling the Swiss pharma giant to gain a presence in the gene therapy area.

The biotech company became the first company to receive approval for a gene therapy in the US for its rare inherited retinal disease treatment Luxturna (voretigene neparvovec).

Spark Therapeutics is also developing a gene therapy for the potential treatment of haemophilia, which has gained positive results in previous clinical studies.

Article by
Lucy Parsons

8th July 2021

From: Marketing



Subscribe to our email news alerts

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....